“Dr. Chirnomas will help the company advance our pipeline of metabolically-driven therapeutics targeting multiple cancers. Debbie comes to Faeth with years of experience in clinical development and medical affairs, which we look to leverage as we continue the clinical development of our lead assets,” said Anand Parikh, J.D., Chief Executive Officer of Faeth Therapeutics.

https://www.businesswire.com/news/home/20230929143840/en